HSA (Singapore) Updates
The latest guidances, approvals, and safety alerts from HSA (Singapore), curated by automated regulatory intelligence.
HSA updates on products found overseas that contain potent ingredients (December 2024) The Health Sciences Authority (HSA) would like to update the public on…
HSA updates on products found overseas that contain potent ingredients (January 2025) The Health Sciences Authority (HSA) would like to update the public on…
Missing Safety Alerts For Smartphone-Compatible Diabetes Devices The Health Sciences Authority (HSA) would like to alert patients and caregivers to a potential…
HSA updates on products found overseas that contain potent ingredients (February 2025) The Health Sciences Authority (HSA) would like to update the public on…
HSA updates on products found overseas that contain potent ingredients (March 2025) The Health Sciences Authority (HSA) would like to update the public on…
HSA updates on products found overseas that contain potent ingredients (April 2025) The Health Sciences Authority (HSA) would like to update the public on…
HSA updates on products found overseas that contain potent ingredients (May 2025) The Health Sciences Authority (HSA) would like to update the public on…
HSA updates on products found overseas that contain potent ingredients (June & July 2025) The Health Sciences Authority (HSA) would like to update the public…
HSA updates on products found overseas that contain potent ingredients (August 2025) The Health Sciences Authority (HSA) would like to update the public on…
Reminder on risk of extrapyramidal side effects with metoclopramide in paediatric patients aged 18 years and below Metoclopramide has been registered in…
Regulatory Updates for Therapeutic Product Registration (effective 30 July 25) As part of HSA’s ongoing initiative to improve regulatory efficiency and enhance…
Launch of eCTD Portal for test submissions HSA is pleased to announce the launch of eCTD Portal for test submission, effective 30 September 2025.
Health Products Regulatory Conference 2025 in conjunction with SMF MedTech Day The Health Products Regulatory Conference 2025, held jointly with SMF MedTech…
Mean applicant screening response time HSA’s target screening turn-around-time from the date of receipt of the application dossier to the date of acceptance or…
Introducing "SHARE" for CTGTP CPP and FSC Launching 17 December 2025 We are pleased to announce the upcoming launch of SHARE (Singapore Health Product Access…
MIV-2 (Do-and-Tell) for CTGTP: Streamlining Post-Approval Change Management for Industry Effective 15 January 2026 We are pleased to introduce our new minor…
Regulatory Updates for Therapeutic Product Registration (effective 16 Jan 26) As part of HSA’s ongoing initiative to improve regulatory efficiency and enhance…
Regulatory Updates: Guidance on Product Defect Reporting and Recall Procedures for Therapeutic Products and Cells, Tissue and Gene Therapy Products (effective…
Update of SG-eCTD version 1. 1 package The Therapeutic Products Branch (TPB) would like to update industry that the SG-eCTD version 1.
Regulatory Updates on Therapeutic Product Registration (1 April 2026) 1. eCTD format officially accepted for regulatory dossier submission HSA is pleased to…